Viracta Therapeutics
VIRX
#11305
Rank
NZ$0.71 M
Marketcap
NZ$0.01788
Share price
0.00%
Change (1 day)
0.39%
Change (1 year)

Earnings for Viracta Therapeutics (VIRX)

Earnings in 2024 (TTM): -NZ$69.79 Million

According to Viracta Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$93.34 Million a decrease over its 2022 earnings that were of -NZ$89.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viracta Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$69.79 Million-25.23%
2023 -NZ$93.34 Million3.78%
2022 -NZ$89.94 Million-57.13%
2021 -NZ$0.21 Billion503.47%
2020 -NZ$34.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 260.69%๐Ÿ‡บ๐Ÿ‡ธ USA